dissolve and was filtered from the hot mixture; the mono-
substituted side product crystallised out first, allowing separation
from the desired di-substituted product, 5.
Synthesis of other achiral NDIs
The procedure followed was identical to that for 5, with the
exception that the respective achiral amino acid was used in
the appropriate quantity (for 6, 2-aminoisobutyric acid; for 7, 1-
aminocyclobutane-1-carboxylic acid). The synthesis of 7 produces
a similar yield as 5 (average 89%) and also rarely requires
purification; 6 and 8 have smaller yields (50–60%) and almost
always require purification by the method quoted above.
Characterisation data
5. (1,1¢(1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7-
(1H,3H, 6H,8H)-diyl)dicyclopropanecarboxylic acid): mp >
300 ◦C; 1H NMR (400 MHz, DMSO-d6) d (ppm): 12.80 (bs,
2H), 8.70 (s, 4H), 1.81 (dd, J = 2.9, 4H), 1.47 (t, J = 2.9, 4H);
13C NMR (1H) (100.62 MHz, DMSO-d6) d (ppm): 172.5, 163.2,
131.1, 126.7, 35.2, 18.7; HRMS (ESI+) calcd for: C22H15N2O8 [M
+ H]+ (m/z): 435.0828, found: 435.0847; Elemental analysis for
5C22H14N2O8·1H2O, calcd: C 60.28%, H 3.40%, N 6.39%, found
C 60.13%, H 3.29%, N 6.30%.
Fig. 11 (a) Molecular structure of 5 showing the atom labelling scheme.
Displacement ellipsoids are scaled to the 50% probability level; b) Unit
cell packing diagram for single crystals of 5.
shown that such a solution is experimentally viable for over 5 h
at room temperature without reheating, significant precipitation
only occurring after more than 16 h). Solutions of the same
concentration of the required chiral NDIs were prepared in TCE.
Quartz cuvettes of path length 5 mm and 10 mm were used
(volume of 2 mL and 4 mL, respectively) for all experiments. An
example of a full data run from 100% chiral to 100% achiral was
recorded as follows, using a 5 mm, 2 mL cuvette with chiral NDI L-
1 and achiral NDI 5 (as seen in Fig. 6(b)). 1 mL of the L-1 solution
was added to the cuvette and the CD signal recorded from 400 to
270 nm three times, smoothed and averaged. 0.1 mL of a solution
of 5 of equal concentration was added, the cuvette shaken and
allowed to stand for 1 min, and the signal again recorded by the
same procedure. This was repeated until the cuvette was filled
and had therefore reached 50% achiral/50% chiral. The whole
experiment was then repeated three times and the results averaged
to minimise experimental error. The averaged CDmax points of each
recording were plotted against percentage chiral NDI present. This
provides the 100–50% chiral part of the data run covering the right
side half of Fig. 6(b). A second experiment was then performed
using the same procedure, but this time starting with achiral 5 and
then adding 0.1 mL volumes of chiral L-1 until 50% achiral/50%
chiral was reached, and this too was repeated three times, averaged
and the CDmax points plotted. This provides the 50–100% achiral
part of the data run covering the left side half of Fig. 6(b). Finally
the experiments were performed again (only a single time) using
H-bond-inactive ester L-3 instead of 5 to provide the control data.
The results shown in Fig. 7 were obtained by the same procedure,
except now using L-2 and D-2 as the chiral NDIs in question, and
L-4 and D-4 for the control esters. Raw CD data plots are shown
in the ESI.†
6. (2,2¢(1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7-
(1H,3H, 6H,8H)-diyl)bis(2-methylpropanoic acid): mp > 300 ◦C;
1H NMR (400 MHz, DMSO-d6) d (ppm): 12.57 (bs, 2H), 8.63
(s, 4H), 1.83 (s, 6H); 13C NMR (1H) (100.62 MHz, DMSO-d6) d
(ppm): 174.3, 164.13, 127.63, 126.40, 63.50, 25.19; HRMS (ESI+)
calcd for: C22H19N2O8 [M + H]+ (m/z): 439.1141 found: 439.1136;
Elemental analysis for 3C22H18N2O8·2H2O, calcd: C 58.67%, H
4.33%, N 6.22%, found: C 58.76%, H 4.21%, N 6.26%.
7. (1,1¢(1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7-
(1H,3H,6H,8H)-diyl)dicyclobutanecarboxylic acid): mp
>
300 ◦C; 1H NMR (400 MHz, DMSO-d6) d (ppm): 13.08 (bs,
2H), 8.65 (s, 4H), 2.86 (dd, J1 = 9.1, J2 = 10.0, 2H), 2.71 (dd,
J1 = 9.1, J2 = 10.0, 2H), 2.27 (dd, J1 = 9.6, J2 = 10.0, 1H),
1.82 (dd, J1 = 9.6, J2 = 10.0, 1H); 13C NMR (1H) (125 MHz,
TCE-d2) d (ppm): 161.60, 143.90, 129.41, 127.92, 126.80, 126.14,
67.48, 52.50, 45.72; HRMS (ESI+) calcd for: C24H19N2O8 [M
+ H]+ (m/z): 463.1141 found: 463.1136; Elemental analysis for
4C24H18N2O8·1H2O, calcd: C 61.66%, H 4.00%, N 6.04%, found
C 61.65%, H 4.05%, N 6.19%.
X-Ray crystallography of 5
Achiral NDI 5 was crystallised from dimethylsulfoxide solution at
room temperature (Fig. 11). Under such conditions 5 was found
to form a monoclinic unit cell with space group P21/c. Unit cell
˚
dimensions: a = 9.0612(2); b = 11.8489(2); c = 28.6964(5) A;
3
˚
volume = 3047.05(10) A . Further details may be found in the
ESI.†
CD experimental procedures
A
solution of 5 (or another achiral NDI) in 1,1,2,2-
13C NMR experimental procedures (C60 uptake study)
tetrachloroethane (TCE) at the required concentration was heated
to 100 ◦C for 1 h with stirring, to aid solubilisation. The solution
of 5 was allowed to cool to room temperature. (Tests have
Mixtures of NDIs L-1 and 5 were made up in the following
proportions: 1 : 0, 1 : 3, 1 : 1, 3 : 1 and 0 : 1. The total molar content
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 4274–4280 | 4279
©